Profile | GDS4284 / 226252_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2614.12 | 87 |
GSM687648 | Patient 402 control | 1803.81 | 82 |
GSM687653 | Patient 403 control | 6499.14 | 95 |
GSM687658 | Patient 404 control | 2113.59 | 84 |
GSM687663 | Patient 411 control | 7030.96 | 96 |
GSM687668 | Patient 422 control | 2573.45 | 87 |
GSM687673 | Patient 424 control | 1816.49 | 83 |
GSM687678 | Patient 425 control | 1864.3 | 83 |
GSM687683 | Patient 427 control | 2387.16 | 86 |
GSM687688 | Patient 428 control | 4280 | 92 |
GSM687695 | Patient 441 control | 1205.68 | 78 |
GSM687699 | Patient 443 control | 2502.69 | 87 |
GSM687704 | Patient 444 control | 5915.91 | 94 |
GSM687707 | Patient 448 control | 1914.03 | 84 |
GSM687712 | Patient 449 control | 1591.31 | 81 |
GSM687719 | Patient 450 control | 1220.38 | 77 |
GSM687724 | Patient 451 control | 2002.52 | 84 |
GSM687728 | Patient 452 control | 1620.12 | 81 |
GSM687646 | Patient 401 treated 24h | 2044.35 | 84 |
GSM687649 | Patient 402 treated 24h | 2237.08 | 85 |
GSM687665 | Patient 411 treated 24h | 6839.8 | 95 |
GSM687651 | Patient 402 treated 4 weeks | 2111.62 | 84 |
GSM687667 | Patient 411 treated 4 weeks | 4924.04 | 93 |
GSM687670 | Patient 422 treated 24h | 2584.58 | 87 |
GSM687671 | Patient 422 treated 4 weeks | 2485.26 | 86 |
GSM687654 | Patient 403 treated 24h | 6554.94 | 95 |
GSM687675 | Patient 424 treated 24h | 1338.19 | 78 |
GSM687685 | Patient 427 treated 24h | 1974.12 | 84 |
GSM687656 | Patient 403 treated 4 weeks | 6752.07 | 95 |
GSM687677 | Patient 424 treated 4 weeks | 2559.13 | 87 |
GSM687687 | Patient 427 treated 4 weeks | 2254.06 | 85 |
GSM687692 | Patient 428 treated 4h | 3201.49 | 89 |
GSM687716 | Patient 449 treated 4h | 2210.18 | 85 |
GSM687722 | Patient 450 treated 4h | 1481.28 | 80 |
GSM687680 | Patient 425 treated 24h | 1961.92 | 83 |
GSM687690 | Patient 428 treated 24h | 4076.62 | 92 |
GSM687700 | Patient 443 treated 24h | 2033.62 | 85 |
GSM687705 | Patient 444 treated 24h | 6512.15 | 95 |
GSM687714 | Patient 449 treated 24h | 1465.29 | 80 |
GSM687721 | Patient 450 treated 24h | 984.132 | 74 |
GSM687682 | Patient 425 treated 4 weeks | 3073.09 | 89 |
GSM687694 | Patient 428 treated 4 weeks | 3446.22 | 90 |
GSM687702 | Patient 443 treated 4 weeks | 2317.25 | 86 |
GSM687718 | Patient 449 treated 4 weeks | 2490.29 | 87 |
GSM687723 | Patient 450 treated 4 weeks | 1567.31 | 81 |
GSM687661 | Patient 404 treated 4h | 1991.43 | 84 |
GSM687710 | Patient 448 treated 4h | 2286.49 | 86 |
GSM687726 | Patient 451 treated 4h | 1939.55 | 84 |
GSM687730 | Patient 452 treated 4h | 3303.2 | 91 |
GSM687660 | Patient 404 treated 24h | 1429.75 | 81 |
GSM687697 | Patient 441 treated 24h | 1713.41 | 83 |
GSM687709 | Patient 448 treated 24h | 1716.39 | 82 |
GSM687725 | Patient 451 treated 24h | 2113.32 | 85 |
GSM687729 | Patient 452 treated 24h | 1042.17 | 77 |
GSM687727 | Patient 451 treated 4 weeks | 4580.18 | 93 |
GSM687731 | Patient 452 treated 4 weeks | 1889.64 | 83 |